ESC Premium Access

The impact of malnutrition-inflammation-atherosclerosis (MIA) syndrome on the prognosis of elderly patients with chronic limb-threatening ischemia after endovascular therapy

Congress Presentation

About the speaker

Doctor Takeshi Sonoda

Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima (Japan)
0 follower

18 more presentations in this session

Impact of polyvascular disease on the prognosis of acute coronary syndrome

Speaker: Professor N. Laraba (Algiers, DZ)

Thumbnail

The efficacy and safety of dual-pathway inhibition therapy among patients with peripheral arterial disease - a meta-analysis

Speaker: Doctor J. Mapili (Manila, PH)

Thumbnail

Total thrombus-formation analysis system (T-TAS) can predict target lesion revascularization in patients undergoing endovascular therapy for critical limb ischemia

Speaker: Doctor N. Kuyama (Osaka, JP)

Thumbnail

Temporal course of vascular response after fluoropolymer paclitaxel-eluting stent implantation for femoropopliteal artery lesions

Speaker: Doctor Y. Tomoi (Fukuoka, JP)

Thumbnail

Pre-dilatation prior to carotid artery stenting in very severe carotid artery stenosis: beneficial or detrimental?

Speaker: Doctor M. Keskin (Istanbul, TR)

Thumbnail

Access the full session

Peripheral Vascular and Cerebrovascular Disease ePosters

Speakers: Doctor T. Sonoda, Professor N. Laraba, Doctor J. Mapili, Doctor N. Kuyama, Doctor Y. Tomoi...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Rethinking therapeutic and diagnostic strategies for chronic coronary syndromes: European and Japanese perspectives after the ISCHEMIA trial – discussion.

27 August 2021

ESC Premium Access

How should I treat my patient with acute heart failure? - Chat Moderator.

27 August 2021

ESC Premium Access

Multimodality cardiac imaging to solve challenging diagnostic questions - Chat Moderator.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk